- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioceltix SA (BCXP)
Assess today's live Bioceltix SA (BCXP) share price, performance and insights using our live Warsaw: BCXP stock exchange data.
Analyse the historical data and Bioceltix SA share price performance charts on this page. Our technical summary section provides analysis on Bioceltix share price buy/sell indicators using real-time data (or discuss the Bioceltix (BCXP) stock price today with other investors in the Bioceltix WA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current WA BCXP share price (ISIN: PLBCLTX00019) to enhance your trading decisions with our free investment tools and resources.
What Is the Bioceltix SA Share Price Today?
The Bioceltix share price today is 83.60.
What Is the Stock Symbol for Bioceltix SA
The stock symbol (or 'ticker') for Bioceltix SA is "BCXP."
What Stock Exchange Does Bioceltix SA Trade On?
Bioceltix SA is listed and trades on the Warsaw stock exchange.
Is Bioceltix SA a Good Stock to Buy?
Determining whether Bioceltix SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Bioceltix SA share price performance charts on this page. Our technical summary section provides analysis on Bioceltix share price buy/sell indicators using real-time data (or discuss the Bioceltix (BCXP) stock price today with other investors in the Bioceltix WA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current WA BCXP share price (ISIN: PLBCLTX00019) to enhance your trading decisions with our free investment tools and resources.
What Is the Bioceltix SA Share Price Today?
The Bioceltix share price today is 83.60.
What Is the Stock Symbol for Bioceltix SA
The stock symbol (or 'ticker') for Bioceltix SA is "BCXP."
What Stock Exchange Does Bioceltix SA Trade On?
Bioceltix SA is listed and trades on the Warsaw stock exchange.
Is Bioceltix SA a Good Stock to Buy?
Determining whether Bioceltix SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Warsaw
Currency in PLN
83.10
-1.30(-1.54%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.10
84.40
52 wk Range
73.00
129.00
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.1084.40
52 wk Range
73.00129.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BCXP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
133.00
Upside
+60.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Bioceltix Company Profile
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Compare BCXP to Peers and Sector
Metrics to compare | BCXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBCXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.1x | −6.6x | −0.5x | |
PEG Ratio | −1.14 | 0.01 | 0.00 | |
Price/Book | 15.4x | 2.6x | 2.6x | |
Price / LTM Sales | - | 6.1x | 3.3x | |
Upside (Analyst Target) | 57.6% | 19.9% | 45.5% | |
Fair Value Upside | Unlock | −1.0% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 133.00
(+60.05% Upside)
Earnings
Latest Release
Nov 28, 2025
EPS / Forecast
-0.89 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Bioceltix (BCXP) Share Price Today?
The live Bioceltix share price today is 83.10
What Stock Exchange Does Bioceltix (BCXP) Trade On?
Bioceltix is listed and trades on the Warsaw Stock Exchange.
What Is the Ticker (Stock Symbol) for Bioceltix?
The stock symbol (also called a 'ticker') for Bioceltix is "BCXP."
What Is the Current Bioceltix Market Cap?
As of today, Bioceltix market capitalisation is 415.63M.
What Is Bioceltix's (BCXP) Earnings Per Share (TTM)?
The Bioceltix EPS is currently -2.89 (Trailing Twelve Months).
When Is the Next Bioceltix Earnings Date?
Bioceltix's next earnings report will be released on 25/02/2026.
Is BCXP a Buy or Sell From a Technical Analyst Perspective?
Based on today's Bioceltix moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Bioceltix Stock Split?
Bioceltix has split 0 times. (See the BCXP stock split history page for full effective split date and price information.)
How Many Employees Does Bioceltix Have?
Bioceltix has 41 employees.
What is the current trading status of Bioceltix (BCXP)?
As of 12 Feb 2026, Bioceltix (BCXP) is trading at a price of 83.10, with a previous close of 84.40. The stock has fluctuated within a day range of 83.10 to 84.40, while its 52-week range spans from 73.00 to 129.00.
What Is Bioceltix (BCXP) Price Target According to Analysts?
The average 12-month price target for Bioceltix is PLN133.00, with a high estimate of PLN133 and a low estimate of PLN133. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +60.05% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.